Page last updated: 2024-09-03

formylmethionyl-leucyl-phenylalanine methyl ester and HIV Coinfection

formylmethionyl-leucyl-phenylalanine methyl ester has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Rosa, A; Lichtner, M; Massetti, AP; Mastroianni, CM; Mengoni, F; Rossi, R; Sauzullo, I; Vullo, V1

Other Studies

1 other study(ies) available for formylmethionyl-leucyl-phenylalanine methyl ester and HIV Coinfection

ArticleYear
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells.
    Clinical and experimental immunology, 2011, Volume: 166, Issue:2

    Topics: CCR5 Receptor Antagonists; Chemokine CCL2; Chemokine CCL4; Chemokine CCL5; Chemotaxis; Chemotaxis, Leukocyte; Cyclohexanes; Dendritic Cells; HIV Fusion Inhibitors; HIV Infections; Humans; Macrophages; Maraviroc; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Receptors, CCR5; Triazoles

2011